Zinc finger protein 197 (ZNF197) is a member of the zinc finger protein family characterized by the presence of zinc finger domains, which are small structural motifs that stabilize protein folds through coordination with a zinc ion. These domains enable ZNF197 to bind DNA, RNA, or other proteins, conferring on it the role of a transcription factor or a mediator in various protein interactions. The '197' denotes its specific identifier within the vast zinc finger protein family, which encompasses hundreds of proteins with diverse functions.The characteristic feature of ZNF197, like other zinc finger proteins, is the ability to interact with DNA in a sequence-specific manner. This interaction typically occurs in the major groove of DNA, where the protein can either promote or repress the transcription of target genes. Through this regulatory role, ZNF197 influences a variety of cellular processes, including development, differentiation, and apoptosis.
The structure of ZNF197 typically includes several zinc finger domains, each consisting of about 30 amino acids that fold around a single zinc ion. These domains are often described as "fingers" that reach into the DNA structure to make contact at specific points, allowing ZNF197 to exert precise control over gene expression.ZNF197 is encoded by the ZNF197 gene located in the human genome. Changes in the expression levels or mutations in the ZNF197 gene can have significant biological consequences and are associated with various diseases, including cancers and developmental disorders. Understanding the specific genes regulated by ZNF197 and its interaction with other proteins can provide insight into its role in these disease processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially affecting gene expression patterns and indirectly influencing ZNF197 activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase (HDAC) inhibitor, which may alter chromatin structure and gene expression, potentially impacting ZNF197. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another HDAC inhibitor, potentially affecting gene regulation and indirectly influencing ZNF197 activity. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor, which can alter gene expression and potentially impact ZNF197. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, affects DNA methylation and gene expression, potentially influencing ZNF197. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective HDAC inhibitor, which may have implications for gene regulation involving ZNF197. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A BET bromodomain inhibitor, potentially influencing gene expression and regulatory mechanisms involving ZNF197. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
Another BET bromodomain inhibitor, which can affect transcription regulation, potentially impacting ZNF197. | ||||||
A-366 | 1527503-11-2 | sc-507495 | 10 mg | $195.00 | ||
A G9a/GLP histone methyltransferase inhibitor, potentially altering epigenetic marks and gene expression relevant to ZNF197. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
A selective EZH2/EZH1 inhibitor, potentially affecting gene expression patterns relevant to ZNF197. | ||||||